Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4300-4304
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Table 1 Clinical characteristics of stage IV gastrointestinal cancer
| linical characteristics | Gastric cancer | Colorectal cancer | ||
| X group | C group | X group | C group | |
| ale/female | 21/11 | 17/12 | 19/16 | 23/12 |
| ge: mean (range/yr) | 63.6 (3683) | 61.0 (3380) | 62.9 (4575) | 60.8 (3474) |
| ecurrence (%) | 14 (43.8) | 14 (48.3) | 8 (22.9) | 9 (25.7) |
| etastasis | ||||
| iver (%) | 17 (53.1) | 16 (55.2) | 21 (60.0) | 22 (62.9) |
| ung (%) | 8 (25.0) | 7 (24.1) | 11 (31.4) | 10 (28.6) |
| eliac lymph node (%) | 21 (65.6) | 21 (72.4) | 14 (40.0) | 15 (42.9) |
| thers (%) | 8 (25.0) | 9 (31.0) | 12 (34.3) | 10 (28.6) |
| revious chemotherapy | 23 (71.9) | 22 (75.9) | 17 (48.6) | 19 (54.3) |
- Citation: Fan L, Liu WC, Zhang YJ, Ren J, Pan BR, Liu DH, Chen Y, Yu ZC. Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies. World J Gastroenterol 2005; 11(28): 4300-4304
- URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i28.4300